Boston Scientific Considers Dropping Proposed Sale Of Neuromodulation Unit
Medtronic Gets FDA Approval For Software To Monitor Diabetes Treatment
Edwards Lifesciences Expects U.S. Launch Of Sapien Heart Valve Within Year
C.R. Bard To Cut Jobs Globally As Part Of Restructuring, Cost-Cutting Plans
Biomet Said Ready To Bid Cash To Buy Smith & Nephew, But Doubts Raised
VNUS Unit Of Covidien Awarded $45.8 Million In TVS, Biolitec Patent Suit
Beckman Coulter Said Weighing Investor Offer To Buy, Take It Private
Half Of Medtronic Patients With Sprint Fidelis Left Without Damage Recourse
Medtronic Served With Federal Subpoena Over Neurostimulation Devices
Medtronic Gains EU Approval For CoreValve’s Heart-Valve Replacement
Abbott, Boston Sci, Medtronic Lead In Using iPads To Promote Devices






.jpg)
.jpg)


Comments